Effects of etomidate administration on cerebral collateral flow

Neurosurgery

Volumn 43, Issue 2, 1998, Pages 317-324

  Robertson, Scott C ^a   Brown III, Pierce ^a   Loftus, Christopher M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Cerebral collaterals; Dog; Etomidate; Microspheres; Stroke

Indexed keywords

ETOMIDATE; IMIDAZOLE; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CRANIOTOMY; DOG; HEART INFARCTION; HYPOTENSION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STROKE; VASCULAR RESISTANCE; VASODILATATION;

ANESTHETICS, INTRAVENOUS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRAIN; COLLATERAL CIRCULATION; DOGS; ETOMIDATE; NEUROPROTECTIVE AGENTS; REGIONAL BLOOD FLOW;

EID: 0031928709     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199808000-00085     Document Type: Article

References (49)

1. Batjer HH: Cerebral protective effects of etomidate: Experimental and clinical aspects. Cerebrovasc Brain Metab Rev 5:17-32, 1993.
2. Batjer HH, Franfurt AI, Purdy PD, Smith SS, Samson DS: Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms. J Neurosurg 68:234-240, 1988.
3. Baumbach GL, Heistad DD: Effects of sympathetic stimulation and changes in arterial pressure on segmental resistance of cerebral vessels in rabbits and cats. Circ Res 52:8-17, 1983.
4. Buckberg GD, Luck JC, Payne DB, Hoffman JIE, Archie JP, Fixler DE: Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 31:598-604, 1971.
5. Busija DW, Heistad DD, Marcus ML: Continuous measurement of cerebral blood flow in anesthetized cats and dogs. Am J Physiol 241:H228-H234, 1981.
6. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical culture. Proc Natl Acad Sci U S A 88:6368-6371, 1991.
7. Evans RH, Hill RG: GABA-mimetic action of etomidate. Experientia 34:1325-1327, 1978.
8. Faraci FM, Breese KR: Nitric oxide mediates vasodilatation in response to activation of N-methyl-D-aspartate receptors in brain. Circ Res 72:476-480, 1993.
9. Faraci FM, Breese KR: Dilatation of cerebral arterioles in response to N-methyl-D-aspartate: Role of CGRP and acetylcholine. Brain Res 640:93-97, 1994.
10. Faraci FM, Brian JE: 7-Nitroindazole inhibits brain nitric oxide synthase and cerebral vasodilatation in response to N-methyl-D-aspartate. Stroke 26:2172-2176, 1995.
11. Faraci F, Heistad D: Regulation of large cerebral arteries and cerebral microvascular pressure. Circ Res 66:8-17, 1990.
12. Frizell RT, Meyer YJ, Borchers DJ, Weprin BE, Allen EC, Pogue WR, Reisch JS, Cherrington AD, Batjer HH: The effects of etomidate on cerebral metabolism and blood flow in a canine model for hypoperfusion. J Neurosurg 74:263-269, 1991.
13. Gillilan LA: Potential collateral circulation to the human cerebral cortex. Neurology 24:941-948, 1974.
14. Ginsberg MD: Neuroprotection in brain ischemia: An update - Part 1. Neuroscientist 1:95-103, 1995.
15. Greene GM, Muhonen MG, Detwiler KN, Heistad DD, Loftus CM: Stem pressure at the origin of intracranial collateral vessels. Am J Physiol 262:H1294-H1297, 1992.
16. Guo J, White JA, Batjer HH: Limited protective effects of etomidate during brainstem ischemia in dogs. J Neurosurg 82:278-283, 1995.
17. Harrison DG, Chapman MP, Christy JP, Marcus ML: Studies of functional site of origin of native coronary collaterals. Am J Physiol 251:H1217-H1224, 1986.
18. Harrison DG, Koyonagi S, Alden B, Marcus ML: Role of overlap perfusion in survival of non-infarcted risk zone following coronary occlusion. Fed Proc 40:602, 1981 (abstr).
19. Heistad DD, Marcus ML, Sandberg S, Abboud FM: Effect of sympathetic nerve stimulation on cerebral blood flow and on large cerebral arteries of dogs. Circ Res 41:342-350, 1977.
20. Heymann MA, Payne BD, Hoffman JI, Rudolph AM: Blood flow measurements with radionucleotide-particles. Prog Cardiovasc Dis 20:55-79, 1977.
21. Hirzel HO, Nelson GR, Sonnenblick EH, Kirk ES: Redistribution of collateral blood flow from necrotic to surviving myocardium following coronary occlusion in the dog. Circ Res 39:214-222, 1976.
22. Hirzel HO, Sonnenblick EH, Kirk ES: Absence of a lateral border zone of intermediate creatine phosphokinase depletion surrounding a central infarct 24 hours after acute coronary occlusion in the dog. Circ Res 39:673-683, 1977.
23. Ikonomidou C, Mosinger JL, Shahid Sales K, Labruyere J, Olney JW: Sensitivity of the developing rat brain to hypoxic/ischemic damage parallels sensitivity to N-methyl-D-aspartate neurotoxicity. J Neurosci 9:2809-2818, 1989.
24. Levy ML, Aranda M, Zelman V, Giannotta SL: Propylene glycol toxicity following continuous etomidate infusion for the control of refractory cerebral edema. Neurosurgery 37:363-371, 1995.
25. Loftus CM, Greene GM, Detwiler KN, Baumbach GL, Heistad DD: Studies of collateral perfusion to canine middle cerebral artery territory. Am J Physiol 259:H560-H566, 1990.
26. Marcus ML, Heistad DD, Ehrhardt JC, Abboud FM: Total and regional cerebral blood flow measurement with 7-10-, 15-, 25-, and 50-μm microspheres. J Appl Physiol 40:501-507, 1976.
27. Mchedlishvili G: Pathological arterial behavior: Vasospasm and vasoparalysis, in Bevan JA (ed): Arterial Behavior and Blood Circulation in the Brain. New York, Consultants Bureau, 1986, pp 228-230.
28. Milde LN, Milde JH, Michenfelder JD: Cerebral functional, metabolic, and hemodynamic effects of etomidate in dogs. Anesthesiology 63:371-377, 1985.
29. Muhonen MG, Greene GM, Heistad DD, Loftus CM: Mechanisms of redistribution of cerebral blood flow during hypercarbia and seizures. Am J Physiol. 266:H2074-H2081, 1994.
30. Muhonen MG, Heistad DD, Faraci F, Loftus CM: Augmentation of Blood flow through cerebral collaterals by inhibition of nitric oxide synthase. J Cereb Blood Flow Metab 14:704-714, 1994.
31. Muhonen MG, Loftus CM, Heistad DD: Effects of adenosine and 2-chloroadenosine on cerebral collateral vessels. J Cereb Blood Flow Metab 15:1075-1081, 1995.
32. Muhonen MG, Robertson SC, Gerdes JS, Loftus CM: Effects of serotonin on cerebral circulation following middle cerebral artery occlusion. J Neurosurg 87:301-306, 1997.
33. Muhonen MG, Sawin PS, Heistad DD, Loftus CM: Pressure-flow relations in canine collateral-dependent cerebrum. Stroke 23:988-994, 1992.
34. Park CK, Nehls DG, Graham DI, Teasdale GM, McCulloch J: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol 24:543-551, 1988.
35. Park CK, Nehls DG, Teasdale GM, McCulloch J: Effect of the NMDA antagonist MK-801 on local cerebral blood flow in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 9:617-622, 1989.
36. Perkins WJ, Lanier WL, Karlsson BR, Milde JH, Michenfelder JD: The effect of the excitatory amino acid receptor antagonist dizocilipine maleate (MK-801) on hemispheric cerebral blood flow and metabolism in dogs: Modification by prior complete cerebral ischemia. Brain Res 498:34-44, 1989.
37. Prior JGL, Hinds CJ, Williams J, Prior PF: The use of etomidate in the management of severe head injury. Intensive Care Med 9:313-320, 1983.
38. Renou AM, Vernhiet J, Macrez P, Constant P, Billerey J, Khadaroo MY, Caillé JM: Cerebral blood flow and metabolism during etomidate anesthesia in man. Br J Anaesth 50:1047-1051, 1978.
39. Robertson SC, Muhonen MG, Gerdes JS, Loftus CM: Effects of serotonin (5-HT) and selective 5-HT receptor antagonists on regional cerebral blood flow after middle cerebral artery occlusion. Surg Forum 47:561-563, 1996.
40. Robertson SC, Wetjen NM, Beer BJ, Loftus CM: Pre- and postischemic effects of the NMDA receptor antagonist dizocilipine maleate (MK-801) on collateral cerebral blood flow. J Neurosurg 87:927-933, 1997.
41. Rosenwasser RH, Jimenez DF, Wending WW, Carlsson C: Routine use of etomidate pretreatment and temporary vessel occlusion during aneurysm surgery. Neurol Res 13:224-228, 1991.
42. Roussel S, Pinard E, Selaz J: Effect of MK-801 on focal brain infarction in normotensive and hypertensive rats. Hypertension 19:40-46, 1992.
43. Symon L: Haemodynamic studies of the leptomeningeal circulation in primates. Proc R Soc Med 61:610-612, 1968.
44. Taylor GA, Trescher WH, Johnston MV, Traystman RJ: Experimental neuronal injury in the newborn lamb: A comparison of N-methyl-D-aspartic acid receptor blockade and nitric oxide synthesis inhibition on lesion size and cerebral hyperemia. Pediatr Res 38:644-651, 1995.
45. Tulleken CAF, van Dieren A, Jonkman J, Kalanda Z: Clinical and experimental experience with etomidate as a brain protective agent. J Cereb Blood Flow Metab 2[Suppl 1]:S92-S97, 1982.
46. Van Reempts J, Borgers M, Van Eyndhoven J, Hermans C: Protective effects of etomidate in hypoxic-ischemic brain damage in the rat: A morphologic assessment. Exp Neurol 76:181-195, 1982.
47. Watson JC, Drummond JC, Patel PM, Sano T, Akrawi W, U HS: An assessment of the cerebral protective effects of etomidate in a model of incomplete forebrain ischemia in the rat. Neurosurgery 30:540-544, 1992.
48. Wauquier A: Brain protective properties of etomidate and flunarizine. J Cereb Blood Flow Metab 2[Suppl 1]:53-56, 1982.
49. Yao H, Markgraf CG, Dietrich WD, Prado R, Watson BD, Ginsberg MD: Glutamate antagonist MK-801 attenuates incomplete but not complete infarction in thrombotic distal middle cerebral artery occlusion in Wistar rats. Brain Res 642:117-122, 1994.